CYP3A7 Gene

HGNC Family Cytochrome P450s (CYP)
Name cytochrome P450, family 3, subfamily A, polypeptide 7
Description This gene encodes a member of the cytochrome P450 superfamily of enzymes, which participate in drug metabolism and the synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. This gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene and is represented by GeneID:100861540. [provided by RefSeq, Jan 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCYP3A7 is a key cytochrome P450 enzyme that is predominantly expressed in the human fetal liver where it plays an essential role in steroid hormone metabolism. In the fetus, CYP3A7 catalyzes the 16α‐hydroxylation of dehydroepiandrosterone (DHEA), DHEA sulfate, and estrone, and is implicated in the metabolism of all‐trans retinoic acid. Although traditionally viewed as a fetal enzyme, genetic variants—most notably the CYP3A7*1C allele—lead to persistent expression in a subset of adults, thereby contributing significantly to total CYP3A activity in tissues such as the liver, endometrium, and placenta. Developmental studies in humans and mouse models further indicate that CYP3A7 expression is tightly regulated by nuclear receptors and epigenetic modifications during the transition from fetal to postnatal life."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of drug metabolism, CYP3A7 displays distinct substrate selectivity and catalytic efficiency compared with its adult counterpart CYP3A4. Although it shares overlapping specificities with other CYP3A enzymes, CYP3A7 generally operates at lower metabolic rates—evident in its slower turnover of inhaled glucocorticoids and alternative binding modes in testosterone hydroxylation—and tends to favor oxidation reactions on substrates like deoxycholate at positions that differ from those preferred by CYP3A4. Moreover, polymorphisms influencing CYP3A7 expression have been shown to affect the pharmacokinetics of immunosuppressants such as tacrolimus and cyclosporine, while for other agents, such as clozapine, CYP3A7 variation does not appear to exert a substantial effect. These findings underscore that the CYP3A7 genotype contributes, alongside other CYP3A isoforms, to interindividual variability in drug clearance and, in certain cases, may also modulate clinical outcomes in oncology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "17"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond drug metabolism, CYP3A7’s activity in steroid clearance has broad implications for endocrine homeostasis and disease susceptibility. Its role in metabolizing DHEA(S) positions it as a modulator of adrenal androgen levels, influencing conditions such as polycystic ovary syndrome, while persistent CYP3A7 expression has been linked to altered estrogen metabolism in reproductive tissues and associations with bone mineral density in postmenopausal women. Novel variants (for example, CYP3A7.1L generated through alternative splicing with pseudogene CYP3AP1) further expand the functional diversity of this enzyme and may explain interethnic differences in xenobiotic and steroid hormone metabolism. Additionally, dysregulation of CYP3A7 expression, such as its marked downregulation observed in conditions like melanosis coli, hints at a broader relevance of this enzyme in pathology."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "22"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Oliver Burk, Heike Tegude, Ina Koch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M202345200"}], "href": "https://doi.org/10.1074/jbc.M202345200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11940601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11940601"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Mohamadi A Sarkar, Vijay Vadlamuri, Shobha Ghosh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.31.1.1"}], "href": "https://doi.org/10.1124/dmd.31.1.1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12485945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12485945"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Pauline Smit, Ron H N van Schaik, Marloes van der Werf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-0307"}], "href": "https://doi.org/10.1210/jc.2005-0307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15985487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15985487"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Sarah C Sim, Robert J Edwards, Alan R Boobis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.fpc.0000171516.84139.89"}], "href": "https://doi.org/10.1097/01.fpc.0000171516.84139.89"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16041241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16041241"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Kayoko Maezawa, Tamihide Matsunaga, Takashi Takezawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytochrome P450 3As gene expression and testosterone 6 beta-hydroxylase activity in human fetal membranes and placenta at full term."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Pharm Bull (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1248/bpb.33.249"}], "href": "https://doi.org/10.1248/bpb.33.249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20118548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20118548"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Carrie A Vyhlidal, Chengpeng Bi, Shui Qing Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.115.068726"}], "href": "https://doi.org/10.1124/dmd.115.068726"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26772622"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26772622"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hang He, Ya-Li Nie, Jiang-Feng Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Pharmacokinet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.dmpk.2016.08.008"}], "href": "https://doi.org/10.1016/j.dmpk.2016.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27727071"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27727071"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Haixing Li, Jed N Lampe "}, {"type": "b", "children": [{"type": "t", "text": "Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2019.108078"}], "href": "https://doi.org/10.1016/j.abb.2019.108078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31445893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31445893"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Laure Elens, Arnaud Capron, Valérie Van Kerckhove, et al. "}, {"type": "b", "children": [{"type": "t", "text": "1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e3282e9a533"}], "href": "https://doi.org/10.1097/FPC.0b013e3282e9a533"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17885626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17885626"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Séverine Crettol, Jean-Pierre Venetz, Massimiliano Fontana, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ther Drug Monit (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FTD.0b013e31818a2a60"}], "href": "https://doi.org/10.1097/FTD.0b013e31818a2a60"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18978522"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18978522"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Eveline Jaquenoud Sirot, Branka Knezevic, Gina Perla Morena, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Psychopharmacol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/JCP.0b013e3181acc372"}], "href": "https://doi.org/10.1097/JCP.0b013e3181acc372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19593168"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19593168"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Beatrice Oneda, Severine Crettol, Evelyne Jaquenoud Sirot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32833225e7"}], "href": "https://doi.org/10.1097/FPC.0b013e32833225e7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19801957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19801957"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Chad D Moore, Jessica K Roberts, Christopher R Orton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.112.046318"}], "href": "https://doi.org/10.1124/dmd.112.046318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23143891"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23143891"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Sylvie E Kandel, Lyrialle W Han, Qingcheng Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.117.078055"}], "href": "https://doi.org/10.1124/dmd.117.078055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28986474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28986474"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Yu-Jie Chen, Jian Zhang, Ping-Ping Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stereoselective Oxidation Kinetics of Deoxycholate in Recombinant and Microsomal CYP3A Enzymes: Deoxycholate 19-Hydroxylation Is an In Vitro Marker of CYP3A7 Activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.119.086637"}], "href": "https://doi.org/10.1124/dmd.119.086637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30918015"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30918015"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Nichola Johnson, Paolo De Ieso, Gabriele Migliorini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-1410"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-1410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26964624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26964624"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yue Dong, Qinxia Xu, Ruidong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2021.146007"}], "href": "https://doi.org/10.1016/j.gene.2021.146007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34688813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34688813"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Mark O Goodarzi, Ning Xu, Ricardo Azziz "}, {"type": "b", "children": [{"type": "t", "text": "Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2008-0403"}], "href": "https://doi.org/10.1210/jc.2008-0403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18445661"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18445661"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "K Bácsi, J P Kósa, G Borgulya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Calcif Tissue Int (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00223-006-0227-8"}], "href": "https://doi.org/10.1007/s00223-006-0227-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17334880"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17334880"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Cristina Rodriguez-Antona, Magnus Axelson, Charlotta Otter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M502309200"}], "href": "https://doi.org/10.1074/jbc.M502309200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15937338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15937338"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Xiao-Yan Pang, Jie Cheng, Jung-Hwan Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and regulation of human fetal-specific CYP3A7 in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2011-1020"}], "href": "https://doi.org/10.1210/en.2011-1020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22253426"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22253426"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Xiao-Αn Li, Yan Zhou, Shu-Χian Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Histopathology of melanosis coli and determination of its associated genes by comparative analysis of expression microarrays."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2015.4126"}], "href": "https://doi.org/10.3892/mmr.2015.4126"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26238215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26238215"}]}]}]}
Synonyms P450-HFLA, CP37, P-450111A7, CYPIIIA7, P-450(HFL33)
Proteins CP3A7_HUMAN
NCBI Gene ID 1551
API
Download Associations
Predicted Functions View CYP3A7's ARCHS4 Predicted Functions.
Co-expressed Genes View CYP3A7's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CYP3A7's ARCHS4 Predicted Functions.

Functional Associations

CYP3A7 has 3,841 functional associations with biological entities spanning 7 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 88 datasets.

Click the + buttons to view associations for CYP3A7 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of CYP3A7 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of CYP3A7 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of CYP3A7 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of CYP3A7 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of CYP3A7 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of CYP3A7 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with CYP3A7 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of CYP3A7 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of CYP3A7 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of CYP3A7 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of CYP3A7 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing CYP3A7 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with CYP3A7 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with CYP3A7 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with CYP3A7 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with CYP3A7 gene/protein from the curated CTD Gene-Disease Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by CYP3A7 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with CYP3A7 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with CYP3A7 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with CYP3A7 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with CYP3A7 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for CYP3A7 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at CYP3A7 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of CYP3A7 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of CYP3A7 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing CYP3A7 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with CYP3A7 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with CYP3A7 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with CYP3A7 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing CYP3A7 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of CYP3A7 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving CYP3A7 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving CYP3A7 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Cellular Component Annotations 2015 cellular components containing CYP3A7 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing CYP3A7 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by CYP3A7 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by CYP3A7 gene from the curated GO Molecular Function Annotations 2023 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of CYP3A7 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of CYP3A7 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CYP3A7 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of CYP3A7 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
GWASdb SNP-Disease Associations diseases associated with CYP3A7 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with CYP3A7 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for CYP3A7 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of CYP3A7 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CYP3A7 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with CYP3A7 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of CYP3A7 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving CYP3A7 protein from the KEGG Pathways dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of CYP3A7 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with CYP3A7 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of CYP3A7 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of CYP3A7 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of CYP3A7 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of CYP3A7 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing CYP3A7 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain CYP3A7 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by CYP3A7 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for CYP3A7 from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of CYP3A7 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
MW Enzyme Metabolite Associations interacting metabolites for CYP3A7 protein from the MW Gene Metabolite Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for CYP3A7 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of CYP3A7 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving CYP3A7 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving CYP3A7 protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2014 pathways involving CYP3A7 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving CYP3A7 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at CYP3A7 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of CYP3A7 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of CYP3A7 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of CYP3A7 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of CYP3A7 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with CYP3A7 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
WikiPathways Pathways 2014 pathways involving CYP3A7 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving CYP3A7 protein from the WikiPathways Pathways 2024 dataset.